ABT's Nutrition rebound and FreeStyle Libre growth fuel momentum, but currency swings and macro pressures could cloud ...
Abbott recalled certain sensors used in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus systems, warning they could produce ...
U.K. FreeDM2 randomized controlled trial: At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs. fingersticks 1,2 ...
Abbott, a global healthcare leader, announced results from the FreeDM2 randomized controlled trial (RCT) showing that people using FreeStyle Libre continuous glucose monitoring (CGM) technology had ...
Dresden, FreeStyle Libre 3 sensor and app on the smartphone. The CGM device is measuring the glucose in the tissue and sending data to the digital health application.(Getty Images/Felix Geringswald) ...
Abbott (NYSE:ABT) today said it launched a new bundle with Withings for its Lingo over-the-counter glucose biosensor.
A wireless sensor the size of a paperclip, Abbott's CardioMEMS HF, can be used routinely by the NHS to monitor patients with chronic heart failure (CHF) in their own homes, according to NICE. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results